Clinical Trial Information Request for Protocol 2023P000400 Title A pilot study evaluating the safety and efficacy of deucravacitinib compared to placebo in the treatment of moderate-to-severe Hidradenitis suppurativa (HS) PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone